Comparative effectiveness research: what is it and why do we need it in nephrology?
Authors:
- Tara I. ChangTCTara I. Chang
- Wolfgang C. WinkelmayerWWWolfgang C. Winkelmayer
- 30 May 2012
- journal article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 27 (6) , 2156-2161
Abstract
The USA leads other industrialized countries in health care spending but lags behind in terms of health outcomes. There has been growing interest in comparative effectiveness research (CER) as a means to identify best practices to create a more efficient and effective health care system. Two key concepts of CER are that it should (i) compare two or more alternative tests, therapies or procedures and (ii) be conducted in persons, clinical settings and conditions that are representative of the real world. The goal of CER is to provide evidence for clinicians, patients, policy makers and others to make informed decisions that will ultimately improve the overall health of specific subgroups and of the population as a whole. In this narrative review, we first describe the strengths and limitations of various types of studies that constitute CER, including randomized clinical trials, observational studies and systematic reviews, providing examples from the nephrology literature. Because of the concerns regarding confounding in observational CER, we also provide an overview of methods to reduce confounding in these types of studies. Finally, we will discuss why CER pertaining to kidney disease care needs to be a top priority in order to move our field from a largely opinion-based specialty to an evidence-based specialty.Keywords
This publication has 41 references indexed in Scilit:
- Comparative effectiveness of incident oral antidiabetic drugs on kidney functionKidney International, 2012
- Segmental and Global Subclasses of Class IV Lupus Nephritis Have Similar Renal OutcomesJournal of the American Society of Nephrology, 2012
- Meta-Analysis of Calcineurin-Inhibitor-Sparing Regimens in Kidney TransplantationJournal of the American Society of Nephrology, 2011
- Statin Use Associates with a Lower Incidence of Acute Kidney Injury after Major Elective SurgeryJournal of the American Society of Nephrology, 2011
- Instrumental variable methods in comparative safety and effectiveness researchPharmacoepidemiology and Drug Safety, 2010
- Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort studyBMJ, 2009
- High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims DataEpidemiology, 2009
- Rosiglitazone Is Associated with Mortality in Chronic Hemodialysis PatientsJournal of the American Society of Nephrology, 2009
- Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and HospitalizationNew England Journal of Medicine, 2004
- The central role of the propensity score in observational studies for causal effectsBiometrika, 1983